| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...865251O |
| P356 | DOI | 10.1371/JOURNAL.PONE.0065251 |
| P932 | PMC publication ID | 3670853 |
| P698 | PubMed publication ID | 23755201 |
| P5875 | ResearchGate publication ID | 237098612 |
| P2093 | author name string | Ichiro Yasuda | |
| Masato Hoshi | |||
| Hisataka Moriwaki | |||
| Osamu Kozawa | |||
| Toshiji Saibara | |||
| Yosuke Osawa | |||
| P2860 | cites work | The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride | Q23919498 |
| Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats | Q28571978 | ||
| Glutathione depletion is involved in the inhibition of procollagen alpha1(I) mRNA levels caused by TNF-alpha on hepatic stellate cells | Q28579226 | ||
| Liver fibrosis | Q29547449 | ||
| Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition | Q32075959 | ||
| Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis | Q33984201 | ||
| Hepatic stellate cells as a target for the treatment of liver fibrosis | Q34391409 | ||
| Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha | Q34425224 | ||
| Tissue inhibitor of metalloproteinase 1 (TIMP-1) deficiency exacerbates carbon tetrachloride-induced liver injury and fibrosis in mice: involvement of hepatocyte STAT3 in TIMP-1 production | Q35073951 | ||
| Bile acid regulation of hepatic physiology: IV. Bile acids and death receptors | Q35102867 | ||
| Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice | Q35760220 | ||
| Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor | Q35997495 | ||
| TIMP-1 deficiency leads to lethal partial hepatic ischemia and reperfusion injury | Q36067201 | ||
| Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways | Q36421523 | ||
| "Let there be bile"--understanding hepatic injury in cholestasis | Q36526816 | ||
| Liver acid sphingomyelinase inhibits growth of metastatic colon cancer | Q36580354 | ||
| Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. | Q36805538 | ||
| Critical role of tumor necrosis factor receptor 1, but not 2, in hepatic stellate cell proliferation, extracellular matrix remodeling, and liver fibrogenesis | Q39552232 | ||
| Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. | Q39632325 | ||
| Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice | Q40310360 | ||
| Possible involvement of reactive oxygen species in D-galactosamine-induced sensitization against tumor necrosis factor-alpha-induced hepatocyte apoptosis | Q40810309 | ||
| Stress-activated protein kinases in the activation of rat hepatic stellate cells in culture. | Q40891185 | ||
| Upstream tissue inhibitor of metalloproteinases-1 (TIMP-1) element-1, a novel and essential regulatory DNA motif in the human TIMP-1 gene promoter, directly interacts with a 30-kDa nuclear protein. | Q40897756 | ||
| Tumor necrosis factor alpha inhibits collagen alpha 1(I) gene expression in rat hepatic stellate cells through a G protein | Q41097795 | ||
| Distinct mechanisms regulate TIMP-1 expression at different stages of phorbol ester-mediated differentiation of U937 cells | Q41121291 | ||
| TNFalpha is required for cholestasis-induced liver fibrosis in the mouse | Q41339503 | ||
| Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis | Q42526474 | ||
| Role of acid sphingomyelinase of Kupffer cells in cholestatic liver injury in mice | Q43263378 | ||
| Caspase activation during hepatocyte apoptosis induced by tumor necrosis factor-alpha in galactosamine-sensitized mice | Q43758752 | ||
| Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy | Q43786938 | ||
| Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration | Q44493296 | ||
| TNF-alpha inhibits liver collagen-alpha 1(I) gene expression through a tissue-specific regulatory region | Q46183132 | ||
| Lack of tumor necrosis factor receptor type 1 inhibits liver fibrosis induced by carbon tetrachloride in mice | Q46370419 | ||
| Roles of AKT and sphingosine kinase in the antiapoptotic effects of bile duct ligation in mouse liver | Q46827700 | ||
| Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis | Q48062721 | ||
| Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation | Q57546894 | ||
| Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration | Q58211740 | ||
| Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated apoptosis: role of nuclear factor-kappaB | Q64380270 | ||
| Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice | Q68134831 | ||
| Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model | Q73229679 | ||
| Lethal hepatic apoptosis mediated by tumor necrosis factor receptor, unlike Fas-mediated apoptosis, requires hepatocyte sensitization in mice | Q73288585 | ||
| Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins | Q74529972 | ||
| Inflammation in response to hepatocellular apoptosis | Q77823653 | ||
| Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1 | Q77932181 | ||
| Systemic mediators induce fibrogenic effects in normal liver after partial bile duct ligation | Q79219306 | ||
| Cytokine blockade inhibits hepatic tissue inhibitor of metalloproteinase-1 expression and up-regulates matrix metalloproteinase-9 in toxic liver injury | Q83951399 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e65251 | |
| P577 | publication date | 2013-06-03 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells | |
| P478 | volume | 8 |
| Q92048632 | A Novel Hepatic Anti-Fibrotic Strategy Utilizing the Secretome Released from Etanercept-Synthesizing Adipose-Derived Stem Cells |
| Q59359696 | Adeno-Associated Virus-Mediated Gene Transfer of Tissue Inhibitor of Metalloproteinases-1 Impairs Neutrophil Extracellular Trap Formation and Ameliorates Hepatic Ischemia and Reperfusion Injury |
| Q35980026 | Characterization of the MMP/TIMP Imbalance and Collagen Production Induced by IL-1β or TNF-α Release from Human Hepatic Stellate Cells |
| Q58580917 | Conditioned Medium from Human Amnion-Derived Mesenchymal Stem Cells Regulates Activation of Primary Hepatic Stellate Cells |
| Q38303313 | Early to Phase II drugs currently under investigation for the treatment of liver fibrosis |
| Q38220772 | Hedgehog signaling pathway as key player in liver fibrosis: new insights and perspectives |
| Q94525578 | Hepatic Fibrosis Assessed Using Fibrosis-4 Index Is Predictive of All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease |
| Q57494347 | Hepatic effect of sofosbuvir and daclatasvir in thioacetamide-induced liver injury in rats |
| Q35213917 | Hepatic inflammation and fibrosis: functional links and key pathways |
| Q41979567 | Improved Hepatoprotective Effect of Liposome-Encapsulated Astaxanthin in Lipopolysaccharide-Induced Acute Hepatotoxicity |
| Q36541005 | Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice. |
| Q89624108 | Liver fibrosis and CD206+ macrophage accumulation are suppressed by anti-GM-CSF therapy |
| Q97423692 | MicroRNA-98 Inhibits Hepatic Stellate Cell Activation and Attenuates Liver Fibrosis by Regulating HLF Expression |
| Q28070168 | New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article |
| Q33706254 | Nonalcoholic fatty liver disease: Diagnostic biomarkers. |
| Q64067609 | P38 inhibition reverses TGFβ1 and TNFα-induced contraction in a model of proliferative vitreoretinopathy |
| Q51300509 | Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats. |
| Q41813284 | Synergistic effect of pro-inflammatory TNFα and IL-17 in periostin mediated collagen deposition: potential role in liver fibrosis |
| Q38685726 | TNFα in liver fibrosis |
| Q38179983 | The significance of YKL-40 protein in liver fibrosis |
| Q52605838 | Tumor necrosis factor-α-mediated hepatocyte apoptosis stimulates fibrosis in the steatotic liver in mice. |
| Q57152398 | Vitamin K1 attenuates bile duct ligation-induced liver fibrosis in rats |
| Q48695566 | WITHDRAWN: The role of TNFα in promoting hepatic MRP4 expression via the p38-Rb-E2F1 pathway in human obstructive cholestasis |
| Q64230111 | and its monomers alleviate liver fibrosis both in mice and LX2 cells by blocking TβR1-Smad2/3 and TNF-α-NF-κB pathways |
Search more.